Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST)

Journal:
The Lancet
Published:
DOI:
10.1016/s0140-6736(25)00439-8
Affiliations:
27
Authors:
31
Go to article
Institutions Authors Share
MRC Clinical Trials Unit (CTU), United Kingdom (UK)
6.000000
 0.19
Uppsala University (UU), Sweden
4.000000
 0.13
The University of Texas at Austin (UT Austin), United States of America (USA)
4.000000
 0.13
Bern University Hospital, Switzerland
2.000000
 0.06
University of Bern (UniBE), Switzerland
2.000000
 0.06
UCL Queen Square Institute of Neurology, United Kingdom (UK)
1.333333
 0.04
University of Basel (UB), Switzerland
1.000000
 0.03
Medical University of Graz (Med Uni Graz), Austria
1.000000
 0.03
National Cerebral and Cardiovascular Center (NCVC), Japan
1.000000
 0.03
The University of Nottingham (UoN), United Kingdom (UK)
1.000000
 0.03
University Medical Center Hamburg-Eppendorf (UKE), UHH, Germany
1.000000
 0.03
University of Glasgow, United Kingdom (UK)
1.000000
 0.03
Royal Devon and Exeter Hospital, United Kingdom (UK)
0.500000
 0.02
University of Exeter, United Kingdom (UK)
0.500000
 0.02
Catholic University of Leuven (KU Leuven), Belgium
0.500000
 0.02
University Hospitals Leuven (UZ Leuven), Belgium
0.500000
 0.02
Liverpool Centre for Cardiovascular Science (LCCS), United Kingdom (UK)
0.500000
 0.02
University of Aalborg (AAU), Denmark
0.500000
 0.02
Skåne University Hospital in Lund, SUS, Sweden
0.500000
 0.02
Lund University (LU), Sweden
0.500000
 0.02
National Hospital for Neurology and Neurosurgery (NHNN), UCLH, United Kingdom (UK)
0.333333
 0.01
UCL, United Kingdom (UK)
0.333333
 0.01
Umeå University (UMU), Sweden
0.333333
 0.01
Danderyd Hospital (DS), Sweden
0.333333
 0.01
Karolinska Institute (KI), Sweden
0.333333
 0.01
Interested in Cardiovascular Medicine and Haematology?